1. Home
  2. CIGI vs GRFS Comparison

CIGI vs GRFS Comparison

Compare CIGI & GRFS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Colliers International Group Inc. Subordinate Voting Shares

CIGI

Colliers International Group Inc. Subordinate Voting Shares

HOLD

Current Price

$110.23

Market Cap

7.5B

Sector

N/A

ML Signal

HOLD

Logo Grifols S.A.

GRFS

Grifols S.A.

HOLD

Current Price

$9.54

Market Cap

6.2B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CIGI
GRFS
Founded
1972
1940
Country
Canada
Spain
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
7.5B
6.2B
IPO Year
N/A
2006

Fundamental Metrics

Financial Performance
Metric
CIGI
GRFS
Price
$110.23
$9.54
Analyst Decision
Buy
Hold
Analyst Count
6
2
Target Price
$175.00
$10.15
AVG Volume (30 Days)
541.1K
438.5K
Earning Date
02-13-2026
07-28-2022
Dividend Yield
0.27%
1.53%
EPS Growth
N/A
N/A
EPS
2.02
0.64
Revenue
$5,558,462,000.00
$8,821,017,248.00
Revenue This Year
$17.67
$5.36
Revenue Next Year
$7.35
$5.15
P/E Ratio
$55.94
$18.24
Revenue Growth
15.27
7.31
52 Week Low
$98.97
$6.19
52 Week High
$171.51
$11.14

Technical Indicators

Market Signals
Indicator
CIGI
GRFS
Relative Strength Index (RSI) 26.50 57.30
Support Level $98.97 $9.07
Resistance Level $147.61 $9.64
Average True Range (ATR) 7.74 0.22
MACD -2.63 0.01
Stochastic Oscillator 23.93 82.30

Price Performance

Historical Comparison
CIGI
GRFS

About CIGI Colliers International Group Inc. Subordinate Voting Shares

Colliers International Group Inc provides commercial real estate professional services and investment management to corporate and institutional clients across different countries around the world. Its operating segments are; Real Estate Services, Engineering, Investment Management, and Corporate. Maximum revenue for the company is generated from its Real Estate Services segment, which offers services like transaction and debt finance services, outsourcing in property management, valuation and advisory, loan servicing, property sales brokerage, and lease brokerage services, among others. Geographically, the company generates maximum revenue from the United States and the rest from Canada, Australia, the United Kingdom, Poland, China, India, and other regions.

About GRFS Grifols S.A.

Grifols SA one of is global specialty plasma therapeutics companies developing, manufacturing and distributing a broad range of biological medicines based on plasma derived proteins. Plasma derivatives are proteins found in human plasma, which once isolated and purified, have therapeutic value. These protein-based therapies extend and enhance the lives of individuals who suffer from chronic and acute, often life-threatening, conditions, including primary and secondary immunological deficiencies, Chronic Inflammatory Demyelinating Polyneuropathy, immune-mediated ITP. Products and services are used to diagnose and treat patients with hemophilia, immune deficiencies, infectious diseases and a range of other medical conditions. Majority of revenue is from USA.

Share on Social Networks: